Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelligent Ultrasound Regulatory News (IUG)

Share Price Information for Intelligent Ultrasound (IUG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.25
Bid: 8.00
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.50 (6.25%)
Open: 8.25
High: 8.25
Low: 8.25
Prev. Close: 8.25
IUG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

25 Apr 2022 07:00

RNS Number : 1282J
Intelligent Ultrasound Group PLC
25 April 2022
 

Intelligent Ultrasound Group plc

(the "Company")

 

Notice of results

Analyst briefing

 

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its unaudited preliminary results for the year ended 31 December 2021 on Tuesday, 3 May 2022.

 

The Company will host a briefing for analysts via ZOOM at 9.30am on Tuesday, 3 May. If you would like to register to dial in to the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email intelligentultrasound@walbrookpr.com.

 

For further information, please contact:

 

Intelligent Ultrasound Group plc 

www. intelligentultrasound.com

 

Stuart Gall, CEO 

Tel: +44 (0)29 2075 6534 

 

 

 

 

Helen Jones, CFO

 

 

 

 

 

 

Cenkos Securities - Nominated Advisor and Broker

Tel: +44 (0)20 7397 8900 

 

Giles Balleny (Corporate Finance)

 

 

Michael Johnson / Julian Morse (Sales) 

 

 

 

 

 

 

 

 

 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com 

 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

 

 

 

 

 

 

 

 

About Intelligent Ultrasound Group

 

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation 

 

Focusses on real-time hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,350 simulators have been sold to over 650 medical institutions around the world.

 

Clinical AI software

 

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound guided needling and incorporates ScanNav Anatomy PNB. 

 

www.intelligentultrasound.com

 

NOTE: ScanNav Anatomy PNB is not yet available for sale in the US or any other territory requiring government approval for this type of product.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORGZGZDDDKGZZM
12
Date   Source Headline
1st May 20247:00 amRNSFinal Results
19th Apr 20247:00 amRNSSonolyst launched on Voluson Signature Series
19th Apr 20247:00 amRNSNotice of Results
29th Feb 20247:00 amRNSNHS Scotland Adopts Classroom to Clinic Training
27th Feb 20243:45 pmRNSScanNav FetalCheck Used in Trial Study
9th Feb 20247:00 amRNSLaunch of Portable NeedleTrainer Plus
9th Jan 20247:00 amRNSTrading Update
22nd Dec 20237:00 amRNSGrant of Share Options
27th Nov 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
23rd Nov 20237:00 amRNSLaunch of ScanNav FetalCheck and its use in study
17th Nov 20237:00 amRNSSonoLystlive now standard on Voluson Expert Series
7th Nov 20237:00 amRNSIntelligent Ultrasound signs research agreement
11th Sep 20237:00 amRNSSonoLystlive launched on Voluson Expert Series
17th Aug 20237:00 amRNSHalf-year Report
3rd Aug 20237:00 amRNSNotice of Results
24th Jul 20237:00 amRNSTrading Update
21st Jun 20234:08 pmRNSResult of AGM
26th May 20237:00 amRNSDirectorate Change
26th May 20237:00 amRNSNotice of AGM and 2022 Report and Accounts
22nd May 20233:57 pmRNSHolding(s) in Company
18th May 20237:00 amRNSMello investor conference
20th Apr 20233:15 pmRNSHolding(s) in Company
20th Apr 20237:00 amRNSFinal Results
23rd Mar 20234:45 pmRNSPDMR/PCA Dealing
15th Mar 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSTrading update
8th Dec 20227:00 amRNSSupport programme in improving global healthcare
30th Nov 20221:12 pmRNSResult of GM
11th Nov 20227:00 amRNSPlacing and Subscription to raise £5.2 million
20th Oct 20227:00 amRNSScanNav Anatomy PNB clearance for sale in the USA
19th Oct 20222:05 pmRNSSecond Price Monitoring Extn
19th Oct 20222:00 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSChange of Auditor
2nd Sep 202211:09 amRNSLaunch of NeedleTrainer 2
18th Aug 20227:00 amRNSHalf-year Report
15th Aug 20227:00 amRNSDirectorate Change
8th Aug 20227:00 amRNSNotice of Results
21st Jul 20227:00 amRNSTrading update
20th Jul 20227:00 amRNSAI technology incorporated into Voluson Expert 22
22nd Jun 202212:08 pmRNSResult of AGM
22nd Jun 20227:00 amRNSAGM Statement
21st Jun 202211:05 amRNSHolding(s) in Company
30th May 20227:00 amRNSNotice of AGM and 2021 Report and Accounts
3rd May 20227:00 amRNSFinal Results
28th Apr 20227:00 amRNSInvestor presentation
25th Apr 20227:00 amRNSNotice of Results
25th Jan 20227:00 amRNSAdditional product agreement with GE Healthcare
13th Jan 20228:12 amRNS2021 Full Year Trading Update
15th Sep 20217:00 amRNSDirectorate Change
19th Aug 20217:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.